T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRR
1476
DELISTED
Carbo Ceramics Inc.
CRR
| $4.95M | ﹤0.01% |
118,775
-396,748
| -77% | -$16M |
|
1477
Galicia Financial Group
GGAL
$7.23B
| $4.92M | ﹤0.01% |
261,600
+177,050
| +209% | +$3.82M |
|
1478
Check Point Software Technologies
CHKP
$13.7B
| $4.9M | ﹤0.01% |
61,630
-370
| -0.6% | -$31.3K |
|
1479
Erie Indemnity
ERIE
$13.4B
| $4.9M | ﹤0.01% |
59,700
| – | – |
|
1480
Children's Place
PLCE
$53.4M
| $4.84M | ﹤0.01% |
73,950
+4,100
| +6% | +$266K |
|
1481
Markel Group
MKL
$22.8B
| $4.81M | ﹤0.01% |
6,013
+106
| +2% | +$82.4K |
|
|
IDTI
1482
DELISTED
Integrated Device Technology I
IDTI
| $4.79M | ﹤0.01% |
220,900
+173,200
| +363% | +$3.74M |
|
1483
Repligen
RGEN
$9.45B
| $4.75M | ﹤0.01% |
+115,000
| New | +$4.21M |
|
|
FL
1484
DELISTED
Foot Locker
FL
| $4.73M | ﹤0.01% |
70,622
+90
| +0.1% | +$5.62K |
|
1485
Reliance Steel & Aluminium
RS
$21.7B
| $4.72M | ﹤0.01% |
77,982
-1,360
| -2% | -$86K |
|
|
WSTC
1486
DELISTED
West Corporation
WSTC
| $4.63M | ﹤0.01% |
154,000
+12,600
| +9% | +$398K |
|
|
INOV
1487
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $4.63M | ﹤0.01% |
166,100
-827,600
| -83% | -$22.2M |
|
1488
Nektar Therapeutics
NKTR
$2.57B
| $4.62M | ﹤0.01% |
24,613
-327
| -1% | -$56.3K |
|
1489
HealthEquity
HQY
$8.83B
| $4.59M | ﹤0.01% |
143,090
-100
| -0.1% | -$2.69K |
|
1490
EPAM Systems
EPAM
$5.24B
| $4.57M | ﹤0.01% |
64,200
-8,600
| -12% | -$589K |
|
1491
Teck Resources
TECK
$31.3B
| $4.56M | ﹤0.01% |
459,500
+442,800
| +2,651% | +$5.72M |
|
1492
Universal Technical Institute
UTI
$1.42B
| $4.53M | ﹤0.01% |
527,200
| – | – |
|
1493
Genpact
G
$5.78B
| $4.46M | ﹤0.01% |
209,100
+12,000
| +6% | +$269K |
|
1494
Clarus
CLAR
$145M
| $4.41M | ﹤0.01% |
479,693
-843,784
| -64% | -$7.95M |
|
1495
Crawford & Co Class A
CRD.A
$632M
| $4.25M | ﹤0.01% |
558,511
+2,700
| +0.5% | +$20.2K |
|
1496
Liberty Media Series C
FWONK
$26B
| $4.14M | ﹤0.01% |
162,861
+21,934
| +16% | +$591K |
|
1497
Tanger
SKT
$4.42B
| $4.11M | ﹤0.01% |
129,780
+100,000
| +336% | +$3.39M |
|
|
FSYS
1498
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $4.07M | ﹤0.01% |
544,610
+1,500
| +0.3% | +$13.9K |
|
|
PRFT
1499
DELISTED
Perficient Inc
PRFT
| $4.06M | ﹤0.01% |
211,000
-9,500
| -4% | -$189K |
|
|
FOGO
1500
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
| $4.05M | ﹤0.01% |
+175,000
| New | +$4.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.